Nanogels for Sustained Ocular Delivery of Brimonidine for Treatment of Glaucoma

摘要

The developed degradable and non-toxic nanogels may have great potential to achieve sustained brimonidine across ocular barriers via both subconjunctival and topical administrations to treat glaucoma.